Cited by 637Health Systems, Economic Evaluations, Quality of LifePharmaceutical Economics and PolicyEconomic and Environmental Valuation

The DOI matches its Crossref record; 179 of the 179 references it cites were found in a registry or an index.

Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold

Grosse, Scott D·2008·Expert Review of Pharmacoeconomics & Outcomes Research

DOI 10.1586/14737167.8.2.165

Open this paper in CoChat — free account

Abstract

Cost-effectiveness analyses, particularly in the USA, commonly use a figure of $50,000 per life-year or quality-adjusted life-year gained as a threshold for assessing the cost-effectiveness of an intervention. The history of this practice is ill defined, although it has been linked to the end-stage renal disease kidney dialysis cost-effectiveness literature from the 1980s. The use of $50,000 as a benchmark for assessing the cost-effectiveness of an intervention first emerged in 1992 and became widely used after 1996. The appeal of the $50,000 figure appears to lie in the convenience of a round number rather than in the value of renal dialysis. Rather than arbitrary thresholds, estimates of willingness to pay and the opportunity cost of healthcare resources are needed.

Integrity signals

Registry

Crossref · 10.1586/14737167.8.2.165

Cites

179 of 179 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Methods for the Economic Evaluation of Health Care Programmes
Drummond, M. E., Sculpher, M. J., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005) · doi:10.1093/oso/9780198529446.001.0001 · Cited by 13,648
Measurement of health state utilities for economic appraisal
Torrance, G. W. (1986) · Journal of Health Economics · doi:10.1016/0167-6296(86)90020-2 · Cited by 2,220
The value of a statistical life: A critical review of market estimates throughout the world
Viscusi, W. K., & Aldy, J. E. (2003) · Journal of Risk and Uncertainty · doi:10.1023/a:1025598106257 · Cited by 2,135
How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.
Laupacis, A., Feeny, D. H., Detsky, A. S., & Tugwell, P. (1992) · Europe PMC (PubMed Central) · Cited by 1,581
Making choices in health: who guide to cost-effectiveness analysis
(2004) · Revista Española de Salud Pública · doi:10.1590/s1135-57272004000300012 · Cited by 1,258
Screening for prostate cancer
Ilić, D., Neuberger, M. M., Djulbegovic, M., & Dahm, P. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004720.pub3 · Cited by 1,219
A study of the quality of life and cost-utility of renal transplantation
Laupacis, A., Keown, P. A., Pus, N., Krueger, H., Ferguson, B., Wong, C. J., & Muirhead, N. (1996) · Kidney International · doi:10.1038/ki.1996.307 · Cited by 1,167
The value of risks to life and health
Viscusi, W. K. (1993) · Cited by 1,118
Net Health Benefits
Stinnett, A. A., & Mullahy, J. (1998) · Medical Decision Making · doi:10.1177/0272989x98018002s09 · Cited by 1,103
Textbook of Cardiovascular Medicine
Topol, E. J. (1997) · Cited by 961

Flagged first, then by citations

Show all 179 references

Research works printed but not linked: 11

Garber, 2004, Health Aff. (Millwood), 4, 284
Laupacis, 1992, CMAJ, 146, 473
Churchill, 1987, Clin. Invest. Med., 10, 14
McCarthy, 1993, Arch. Intern. Med., 153, 1107, 10.1001/archinte.1993.00410090057007 · DOI
Owens, 1993, Med. Decis. Making, 13, 395
Kallmes, 1997, AJNR Am. J. Neuroradiol., 18, 1453
Fox-Rushby, 2001, Bull. World Health Organ., 79, 679
Viscusi, 1993, J. Econ. Lit., 31, 1912
Cutler, 2001, Health Aff. (Millwood), 20, 11
Hammitt, 2005, ISPOR Connections, 11, 7
10.1038/ki.1996.307 · DOI

Sorted by citations

Items 401–500 of 637

Comparing the cost-effectiveness of linezolid to trimethoprim/sulfamethoxazole plus rifampicin for the treatment of methicillin-resistant Staphylococcus aureus infection: a healthcare system perspective
von Dach, E., Morel, C. M., Murthy, A. K., Pagani, L., Macedo-Viñas, M., Olearo, F., & Harbarth, S. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.02.011 · Cited by 9
A retrospective cost analysis of angioplasty compared to bypass surgery for lower limb arterial disease in an Australian tertiary health service
Ngu, N. L. Y., Lisik, J. P., Varma, D., & Goh, G. S. (2018) · Journal of Medical Imaging and Radiation Oncology · doi:10.1111/1754-9485.12696 · Cited by 9
Cost-Effectiveness of Postoperative Drug Rehabilitation for Injection Drug Users
Tyerman, Z. M., Shah, S. M., Mehaffey, J. H., Wanchek, T. N., Hawkins, R. B., McQuade, E. T. R., Shannon, A. H., Ailawadi, G., & Yount, K. W. (2019) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2019.11.011 · Cited by 9
Adherence With Therapeutic Regimens
Giannetti, V. J., & Kamal, K. M. (2014) · Journal of Pharmacy Practice · doi:10.1177/0897190014549840 · Cited by 9
Cost-Effectiveness of Technologies for the Treatment of Spinal Muscular Atrophy: A Systematic Review of Economic Studies
Motta-Santos, A. S., Noronha, K., Reis, C. D. B., Freitas, D., Carvalho, L. M. D. A., & Andrade, M. V. (2024) · Value in Health Regional Issues · doi:10.1016/j.vhri.2024.02.002 · Cited by 9
Long‐term cost‐effectiveness of tirzepatide for individuals with type 2 diabetes and comorbid obesity
Tang, M., Shi, L., Guan, D., Winberg, D., Tang, T., Shao, H., & Fonseca, V. A. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16466 · Cited by 8
A Group of 500 Women Whose Health May Depart Notably From the Norm: Protocol for a Cross-Sectional Survey
Schnelle, C., Minford, E. J., McHardy, V., & Keep, J. (2017) · JMIR Research Protocols · doi:10.2196/resprot.7993 · Cited by 8
Preventing Leading Causes of Death: Systematic Review of Cost-Utility Literature
Khushalani, J. S., Song, S., Calhoun, B. H., Puddy, R. W., & Kucik, J. E. (2021) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2021.07.019 · Cited by 8
Are Medical Devices Cost-Effective?
Chambers, J. D., Silver, M. C., Berklein, F. C., Cohen, J. T., & Neumann, P. J. (2021) · Applied Health Economics and Health Policy · doi:10.1007/s40258-021-00698-6 · Cited by 8
Cost-effectiveness of bariatric surgery for severely obese adults with diabetes
for the Members of the Evidence Based Reviews in Surgery Group, Henteleff, H., Birch, D. W., & Hallowell, P. T. (2013) · Canadian Journal of Surgery · doi:10.1503/cjs.020713 · Cited by 8
Cost-effectiveness of tiotropium versus salmeterol: the POET-COPD trial
Hoogendoorn, M., Al, M., Beeh, K.-M., Bowles, D., von der Schulenburg, J. M. G., Lungershausen, J., Monz, B. U., Schmidt, H., Vogelmeier, C. F., & Mölken, M. R. (2012) · European Respiratory Journal · doi:10.1183/09031936.00027212 · Cited by 8
Hepatic Resection for Disappearing Liver Metastasis: a Cost-Utility Analysis
Spolverato, G., Vitale, A., Ejaz, A. M., Cosgrove, D. C., Cowzer, D., Cillo, U., & Pawlik, T. M. (2015) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-015-2873-5 · Cited by 8
Possible Impact of Incremental Cost-Effectiveness Ratio (ICER) on Decision Making for Cancer Screening in Hong Kong: A Systematic Review
Wong, C. K. H., Lang, B. H., Guo, V. Y., & Lam, C. L. K. (2016) · Applied Health Economics and Health Policy · doi:10.1007/s40258-016-0266-x · Cited by 9
Real-Life Treatment Paradigms Show Adalimumab Is Cost-Effective for the Management of Ulcerative Colitis
Beilman, C. L., Thanh, N. X., Ung, V., Ma, C., Wong, K., Kroeker, K. I., Lee, T., Wang, H., Ohinmaa, A. E., Jacobs, P., et al. (2016) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2016/5315798 · Cited by 8
The changing cost to prevent diabetes: A retrospective analysis of the Diabetes Prevention Program
Carris, N. W., Cheng, F., & Kelly, W. N. (2017) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2017.05.015 · Cited by 8
It Takes a Village Coach: Cost-Effectiveness of an Intervention to Improve Diet and Physical Activity Among Minority Women
Buder, I., Zick, C. D., Waitzman, N. J., Simonsen, S. E., Sunada, G. R., & Digre, K. B. (2018) · Journal of Physical Activity and Health · doi:10.1123/jpah.2017-0285 · Cited by 8
Cost-effectiveness of measles control during elimination in Ontario, Canada, 2015
Ramsay, L. C., Crowcroft, N. S., Thomas, S., Aruffo, E., Teslya, A., Heffernan, J. M., Gournis, E., Hiebert, J., Jaeger, V., Jiaravuthisan, M., et al. (2019) · Eurosurveillance · doi:10.2807/1560-7917.es.2019.24.11.1800370 · Cited by 8
Patient-Centered Outcomes in Radiation Oncology
Grewal, A. S., & Berman, A. T. (2019) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2019.08.012 · Cited by 8
Cost-effectiveness of a comprehensive immunization program serving high-risk, uninsured adults
Wilson, K. J., Brown, H. S., Patel, U., Tucker, D., & Becker, K. (2019) · Preventive Medicine · doi:10.1016/j.ypmed.2019.105860 · Cited by 8
Cost-effectiveness of vibegron for the treatment of overactive bladder in the United States
Chen, J. V., Klein, T. M., Nesheim, J., & Mudd, P. N. (2022) · Journal of Medical Economics · doi:10.1080/13696998.2022.2115754 · Cited by 8
Inhaled Aztreonam Lysine versus Inhaled Tobramycin in Cystic Fibrosis. An Economic Evaluation
Schechter, M. S., Trueman, D., Farquharson, R., Higuchi, K., & Daines, C. L. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201312-453oc · Cited by 8
Does combining antiretroviral agents in a single dosage form enhance quality of life of HIV/AIDS patients? A cost-utility study
Ganguli, A. X., Wang, J., & Gourley, D. R. (2011) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2010.12.004 · Cited by 8
Measuring the Cost and Value of Quality Improvement Initiatives for Local Health Departments
Chen, L., Wilson, F. A., Gregg, A., Gupta, N., Bekmuratova, S., & Palm, D. W. (2017) · Journal of Public Health Management and Practice · doi:10.1097/phh.0000000000000552 · Cited by 8
Systematic review of health economic studies in cranial neurosurgery
Ryu, W. H. A., Yang, M. M. H., Muram, S., Jacobs, W. B., Casha, S., & Riva-Cambrin, J. K. (2018) · Neurosurgical FOCUS · doi:10.3171/2018.2.focus17792 · Cited by 8
Optimal coinsurance rates for a heterogeneous population under inequality and resource constraints
Schell, G. J., Garcia, G. P., Lavieri, M. S., Sussman, J. B., & Hayward, R. A. (2018) · IISE Transactions · doi:10.1080/24725854.2018.1499053 · Cited by 9
The cost-effectiveness of early goal-directed therapy: an economic evaluation alongside the ARISE trial
Higgins, A. M., Peake, S., Bellomo, R., Cooper, D. J., Delaney, A. P., Howe, B. D., Nichol, A., Webb, S. A. R., Williams, P. J., & Harris, A. (2021) · Critical Care and Resuscitation · doi:10.51893/2021.3.oa10 · Cited by 8
The cost-effectiveness of collegiate recovery programs
de Martell, S. C., Steiker, L. H., Springer, A. E., Jones, J. A., Eisenhart, E., & Brown, H. S., III (2022) · Journal of American College Health · doi:10.1080/07448481.2021.2024206 · Cited by 7
The cost-effectiveness of zuranolone versus selective serotonin reuptake inhibitors for the treatment of postpartum depression in the United States
O’Callaghan, L., Chertavian, E., Johnson, S. J., Ferries, E., & Deligiannidis, K. M. (2024) · Journal of Medical Economics · doi:10.1080/13696998.2024.2327946 · Cited by 8
Cost-effectiveness of screening for chronic kidney disease using a cumulative eGFR-based statistic
Zafarnejad, R., Chen, Q., & Griffin, P. M. (2024) · PLoS ONE · doi:10.1371/journal.pone.0299401 · Cited by 7
Economic Impact of Drug Allergy
Li, Y., Minhas, J. S., & Blumenthal, K. G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-48551-7.00002-x · Cited by 7
An alternative approach identified optimal risk thresholds for treatment indication: an illustration in coronary heart disease
van Giessen, A., de Wit, G. A., Moons, K. G. M., Dorresteijn, J. A. N., & Koffijberg, H. (2017) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2017.09.020 · Cited by 7
Cost‐effectiveness of an adherence‐enhancing intervention for gout based on real‐world data
Lin, L. W., Teng, G. G., Lim, A. Y. N., Yoong, J., Zethraeus, N., & Wee, H. L. (2018) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.13446 · Cited by 7
Economic evaluation of polatuzumab-bendamustine-rituximab vs. tafasitamab-lenalidomide in transplant-ineligible R/R DLBCL
Calamia, M., McBride, A., & Abraham, I. L. (2021) · Journal of Medical Economics · doi:10.1080/13696998.2021.2007704 · Cited by 7
Mitigating the mental health consequences of mass shootings: An in-silico experiment
Abdalla, S. M., Cohen, G. H., Tamrakar, S., Sampson, L., Moreland, A. D., Kilpatrick, D. G., & Galea, S. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101555 · Cited by 7
Bevacizumab vs. Ranibizumab in Preserving or Improving Vision in Patients with Wet, Age-Related Macular Degeneration: A cost-effectiveness Review
Nwanze, C. C., Akinwale, A., & Adelman, R. A. (2012) · Clinical Medicine Insights Therapeutics · doi:10.4137/cmt.s7439 · Cited by 7
Cost-Effectiveness of Ensuring Hepatitis B Protection for Previously Vaccinated Healthcare Personnel
Hoerger, T. J., Bradley, C. L., Schillie, S. F., Reilly, M. L., & Murphy, T. V. (2014) · Infection Control and Hospital Epidemiology · doi:10.1086/676865 · Cited by 7
Palivizumab in preventing respiratory syncytial virus-related hospitalization in high-risk infants
Resch, B. (2008) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.8.6.529 · Cited by 7
Cost-effectiveness of Adding an Agent That Improves Immune Responses to Initial Antiretroviral Therapy (ART) in HIV-Infected Patients: Guidance for Drug Development
Morris, B. L., Scott, C. A., Wilkin, T. J., Sax, P. E., Gulick, R. M., Freedberg, K. A., & Schackman, B. R. (2012) · HIV Clinical Trials · doi:10.1310/hct1301-1 · Cited by 7
Weighting Health Outcomes by Socioeconomic Position Using Stated Preferences
Lal, A., Siahpush, M., Moodie, M., Peeters, A., & Carter, R. (2017) · PharmacoEconomics - Open · doi:10.1007/s41669-017-0036-1 · Cited by 6
Cost-effectiveness analysis of radiotherapy techniques for whole breast irradiation
Xie, Y., Guo, B., & Zhang, R. (2021) · PLoS ONE · doi:10.1371/journal.pone.0248220 · Cited by 7
Comparison of effectiveness and safety of direct oral anticoagulants versus vitamin-k antagonists in elderly patients with atrial fibrillation: a systematic review and cost-effectiveness analysis protocol
Wang, N., Shen, N., Wu, Y., Zhang, C., Pan, M.-M., Qian, Y. N., & Gu, Z. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.02.109 · Cited by 7
Editorial: Role of Health Economic Data in Policy Making and Reimbursement of New Medical Technologies
Jakovljević, M., & Yamada, T. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00662 · Cited by 7
Risk-stratified hepatocellular carcinoma screening according to the degree of obesity and progression to cirrhosis for diabetic patients with metabolic dysfunction-associated steatotic liver disease (MASLD) in Japan: a cost-effectiveness study
Kowada, A. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-080549 · Cited by 7
Cost-effectiveness of lumbar fenestration surgery in the Japanese universal health insurance system
Fujimori, T., Miwa, T., Iwasaki, M., & Oda, T. (2018) · Journal of Orthopaedic Science · doi:10.1016/j.jos.2018.06.020 · Cited by 6
Development of early diagnosis of Parkinson’s disease and comprehensive economic analysis of the effect of its implementation
Gusev, E. I., Blokhin, V. E., Vartanov, S., Martynov, M. Y., Катунина, Е. А., Alesenko, A. V., Denisova, I. A., Pavlova, E., Polterovich, V. M., Kucheryanu, V. G., et al. (2021) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro20211210119 · Cited by 6
Adopting Health Economic Research in Radiation Oncology: A Perspective From Low- or Middle-Income Countries
Sinha, S., Laskar, S. G., Wadasadawala, T., Krishnatry, R., Lievens, Y. N., & Agarwal, J. P. (2022) · JCO Global Oncology · doi:10.1200/go.21.00374 · Cited by 6
Modelled Distributional Cost-Effectiveness Analysis of Childhood Obesity Interventions: A Demonstration
Killedar, A., Lung, T. W.-C., Taylor, R. W., & Hayes, A. (2023) · Applied Health Economics and Health Policy · doi:10.1007/s40258-023-00813-9 · Cited by 6
Cost-effectiveness Analysis of Abdominal-based Autogenous Tissue and Tissue-expander Implant following Mastectomy
Thoma, A., Avram, R., Cin, A. D., Murphy, J., Duku, E., & Xie, F. (2020) · Plastic & Reconstructive Surgery Global Open · doi:10.1097/gox.0000000000002986 · Cited by 6
Long-term clinical and cost-effectiveness of collaborative care in people with uncontrolled type 2 diabetes mellitus and polypharmacy: A multicenter randomized controlled trial
Xu, Y.-Q., Tan, C. W. Y., Tsou, K. Y. K., Tan, D. H. Y., Gallagher, P., & Lee, J. V. (2021) · Primary care diabetes · doi:10.1016/j.pcd.2021.12.013 · Cited by 6
Better and faster is cheaper
Kobayashi, E. S., & Dimmock, D. (2022) · Human Mutation · doi:10.1002/humu.24422 · Cited by 8
Translation of Collaborative Dementia Care Management into Different Healthcare Settings: Study Protocol for a Multicenter Implementation Trial (DCM:IMPact)
Platen, M., Hoffmann, W. U., Rädke, A., Scharf, A., Mohr, W., Mühlichen, F., & Michalowsky, B. (2022) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-220045 · Cited by 6
Health Economics of Infectious Diseases
Welte, R., Leidl, R., Greiner, W., & Postma, M. J. (2009) · Statistics in the health sciences · doi:10.1007/978-0-387-93835-6_15 · Cited by 6
A comparison of individualized treatment guided by VeriStrat with standard of care treatment strategies in patients receiving second-line treatment for advanced non-small cell lung cancer: A cost-utility analysis
Nelson, R. E., Stenehjem, D. D., & Akerley, W. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.08.021 · Cited by 6
The Core Value of Cost-Effectiveness Analyses∗
Dhruva, S. S., & Krumholz, H. M. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.11.013 · Cited by 6
Benefit of adjunct universal rectal screening for Chlamydia genital infections in women attending Canadian sexually transmitted infection clinics
Thành, N. X., Akpinar, İ., Gratrix, J., Plitt, S. S., Smyczek, P., Read, R., Jacobs, P., Wong, T., & Singh, A. E. (2017) · International Journal of STD & AIDS · doi:10.1177/0956462417704344 · Cited by 6
Tobacco Dependence Treatment Grants: A Collaborative Approach to the Implementation of WHO Tobacco Control Initiatives
Nolan, M. B., Kemper, K. E., Glynn, T. J., Hurt, R. D., & Hays, J. T. (2018) · Journal of Environmental and Public Health · doi:10.1155/2018/8429738 · Cited by 6
Cost-Effectiveness of the Biozorb Device for Radiation Planning in Oncoplastic Surgery
Rashad, R., Huber, K. E., & Chatterjee, A. (2018) · Cancer and Clinical Oncology · doi:10.5539/cco.v7n2p23 · Cited by 6
Cost-effectiveness of fulvestrant 250 mg versus 500 mg in postmenopausal women with estrogen receptor-positive metastatic breast cancer and disease progression after antiestrogen therapy
Newman, M. J., Jones, L. T., Kraft, J. M., Lee, A. R., Lech, G. M., Farrell, N. M., Phantumvanit, V., & Edwards, R. A. (2012) · Journal of Oncology Pharmacy Practice · doi:10.1177/1078155212438253 · Cited by 6
OR Applications in Disease Screening
Güneş, E. D., & Örmeci, E. L. (2017) · International series in management science/operations research/International series in operations research & management science · doi:10.1007/978-3-319-65455-3_12 · Cited by 6
Of mad cows and bolted horses: the economics of blood safety
Murphy, W. G. (2012) · Transfusion · doi:10.1111/j.1537-2995.2012.03931.x · Cited by 6
Economics and the New Generation of Targeted Therapies for Non-Small Cell Lung Cancer
Ramsey, S. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq012 · Cited by 6
Cost-Effectiveness of Diffusion Weighted MRI Versus Planned Second-Look Surgery for Cholesteatoma
Patel, T. A., Ettyreddy, A. R., Cheng, T. Z., Smith, K. J., Sridharan, S., & McCall, A. A. (2024) · Annals of Otology Rhinology & Laryngology · doi:10.1177/00034894241250253 · Cited by 5
Value and Health Care Policy Ramifications of Rotator Cuff Repair
Srikumaran, U., Hannan, C. V., Higgins, L. D., & Warner, J. J. P. (2016) · Techniques in Orthopaedics · doi:10.1097/bto.0000000000000177 · Cited by 5
Cost‐effectiveness of Canal Wall‐Up vs Canal Wall‐Down Mastoidectomy: A Modeling Study
Bu, D. D., Schwam, Z. G., Kaul, V. F., Wong, K., Fan, C. J., Wanna, G. B., Cosetti, M. K., & Perez, E. R. (2022) · Otolaryngology · doi:10.1177/01945998221076051 · Cited by 5
Cost-effectiveness of using protons for breast irradiation aiming at minimizing cardiotoxicity: A risk-stratification analysis
Li, G., Xia, Y., Huang, Y., Okat, D., Qiu, B., Doyen, J., Bondiau, P., Bénézery, K., Gao, J., & Qian, C. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.938927 · Cited by 5
The cost-effectiveness of long-term post-treatment peer recovery support services in the United States
de Martell, S. C., Moore, M. B., Wang, H., Steiker, L. H., Wilkerson, J. M., Ranjit, N., McCurdy, S., & Brown, H. S. (2025) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2024.2406251 · Cited by 5
Die Nutzung von Informationswertanalysen in Entscheidungen über angewandte Forschung
Rogowski, W. H., Grosse, S. D., Meyer, E., John, J., & Palmer, S. (2012) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-012-1474-7 · Cited by 5
Cost-Effectiveness of Liver Cancer Screening in Adults at High Risk for Liver Cancer in the Republic of Korea
Lee, Y. H., Choi, K. S., Jun, J. K., Suh, M., Lee, H.-Y., Kim, Y. N., Nam, C. M., Park, E., & Cho, W.-H. (2014) · Cancer Research and Treatment · doi:10.4143/crt.2014.46.3.223 · Cited by 5
Current State of Health Economic Analyses for Low-Grade Glioma Management: A Systematic Review
Tuohy, K. J., Fernandez, A., Hamidi, N., Padmanaban, V., & Mansouri, A. (2021) · World Neurosurgery · doi:10.1016/j.wneu.2021.05.112 · Cited by 5
Cost-Effectiveness of a School-Based Chlamydia Screening Program, Duval County, FL
Wang, L. Y., Owusu‐Edusei, K., Parker, J. T., & Wilson, K. (2019) · The Journal of School Nursing · doi:10.1177/1059840519890026 · Cited by 5
Review of the economic evaluations of hormonal therapy for patients with locally advanced prostate cancer
Hatoum, H. T., Crawford, E. D., Nielsen, S. K., Lin, S., & Marshall, D. C. (2013) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/erp.13.12 · Cited by 5
Radiofrequency ablation plus nucleotide analogous for hepatitis B virus-related hepatocellular carcinoma: a cost-effectiveness analysis.
Liu, B., Wei, M., Liu, F., Chen, S., Peng, Z., Li, B., Zhou, Q., Wang, H., Peng, S., & Kuang, M. (2018) · Europe PMC (PubMed Central) · Cited by 5
Cost‐Effectiveness Analysis, Health‐Care Policy, and Operations Research Models
Zaric, G. S. (2010) · Wiley Encyclopedia of Operations Research and Management Science · doi:10.1002/9780470400531.eorms0202 · Cited by 5
Verifying the value of existing frameworks for formulary review at a large academic health system: assessing inter-rater reliability
Karas, B. L., Picone, M. F., Werner, S., & Holsopple, M. (2021) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2021.27.4.488 · Cited by 4
Better preservation of erectile function in localized prostate cancer patients with modern proton therapy: Is it cost‐effective?
Li, G., Xia, Y., Huang, Y., Okat, D., Qiu, B., Doyen, J., Bondiau, P., Bénézery, K., Gao, J., & Qian, C. (2022) · The Prostate · doi:10.1002/pros.24417 · Cited by 4
Innovative methods of determining health expenditure efficiency are urgently needed
Cao, Z. L., & Chen, S. (2023) · The Lancet Global Health · doi:10.1016/s2214-109x(23)00196-1 · Cited by 4
Balloon Spacer Implant Is an “Intermediate Value” Innovation Relative to Partial Repair for Full‐Thickness Massive Rotator Cuff Repairs: A Cost‐Utility Analysis
Wang, K. Y., Kishan, A., Abboud, J. A., Verma, N. N., & Srikumaran, U. (2024) · Arthroscopy The Journal of Arthroscopic and Related Surgery · doi:10.1016/j.arthro.2024.06.023 · Cited by 4
Cost-effectiveness analysis of antiretroviral therapy in a cohort of HIV-infected patients starting first-line highly active antiretroviral therapy during 6 years of observation
Colombo, G. L., Maggiolo, F., Matteo, S. D., Bruno, G. M., Astuti, N., Filippo, E. D., Masini, G., & Bernardini, C. (2015) · Patient Related Outcome Measures · doi:10.2147/prom.s63586 · Cited by 4
Methodological and applied concerns surrounding age-related weighting within health economic evaluation
Petrou, S. (2014) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.2014.940320 · Cited by 4
Incremental cost-effectiveness of trauma service improvements for road trauma casualties: experience of an Australian major trauma centre
Dinh, M. M. Q., Bein, K. J., Hendrie, D. V., Gabbe, B. J., Byrne, C. M., & Ivers, R. (2015) · Australian Health Review · doi:10.1071/ah14205 · Cited by 4
Prioritizing HIV comparative effectiveness trials based on value of information: generic versus brand-name ART in the US
Pei, P. P., Weinstein, M. C., Li, X. C., Hughes, M. D., Paltiel, A. D., Hou, T., Parker, R. A., Gaynes, M. R., Sax, P. E., Freedberg, K. A., et al. (2015) · HIV Clinical Trials · doi:10.1080/15284336.2015.1123942 · Cited by 4
Cost-effectiveness of Open Reduction and Internal Fixation Compared With Hemiarthroplasty in the Management of Complex Proximal Humerus Fractures
Thorsness, R. J., Iannuzzi, J. C., Shields, E. J. W., Noyes, K., & Voloshin, I. (2018) · Journal of Shoulder and Elbow Arthroplasty · doi:10.1177/2471549217751453 · Cited by 4
Pricing a Year of Progression-Free Survival
DiMagno, S. S. P., & Emanuel, E. (2018) · JAMA Dermatology · doi:10.1001/jamadermatol.2018.3753 · Cited by 4
Potable Reuse of Coalbed Methane-Produced Waters in Developing Country Contexts—Could the Benefits Outweigh the Costs to Facilitate Coal Transitions?
Singh, U., & Colosi, L. M. (2019) · Energies · doi:10.3390/en13010154 · Cited by 4
Impact of Pharmacogenomic Information on Values of Care and Quality of Life Associated with Codeine and Tramadol-Related Adverse Drug Events
Zhu, Y., Lopes, G. S., Bielinski, S. J., Borah, B. J., Larson, N. B., Moyer, A. M., Olson, J. E., Wang, L., Weinshilboum, R. M., & Sauver, J. L. S. (2021) · Mayo Clinic Proceedings Innovations Quality & Outcomes · doi:10.1016/j.mayocpiqo.2020.08.009 · Cited by 4
Cost Utility of cognition-enhancing interventions for individuals with first-episode psychosis: a naturalistic evaluation
Breitborde, N. J. K., Bell, E. K., Woolverton, C. B., Pine, J. G., Waslter, H., & Moe, A. M. (2021) · Cost Effectiveness and Resource Allocation · doi:10.1186/s12962-021-00292-6 · Cited by 5
Return on investment of Canadian tobacco control policies implemented between 2001 and 2016
Tarride, J., Blackhouse, G., Guindon, G. E., Chaiton, M., Planinac, L. C., & Schwartz, R. M. (2021) · Tobacco Control · doi:10.1136/tobaccocontrol-2021-056473 · Cited by 4
Quantifying the benefits of increasing decision-making frequency for health applications with regular decision epochs
Zhang, S., Suen, S., Sundaram, V., & Gong, C. L. (2024) · IISE Transactions · doi:10.1080/24725854.2024.2321492 · Cited by 4
A review of cost–effectiveness comparisons for overactive bladder treatments: which is the most cost-effective for improving quality of life?
Giannitsas, K., & Athanasopoulos, A. (2015) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.2015.1011132 · Cited by 4
Transforming Disciplinary Traditions Comment on "Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling"
Lehoux, P., & da Silva, H. P. (2019) · International Journal of Health Policy and Management · doi:10.15171/ijhpm.2019.130 · Cited by 4
Living in a material world: tumor-treating fields at the top of the charts
Schiff, D., & Schrag, D. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now138 · Cited by 4
Cost-Effectiveness of Expanded Newborn Screening in Texas
Hsu, C.-F., Kang, K., Lee, Y. L., & Chie, W. (2013) · Value in Health · doi:10.1016/j.jval.2013.06.019 · Cited by 4
Is Blepharoplasty Cost-effective? Utility Analysis of Dermatochalasis and Cost-effectiveness Analysis of Upper Eyelid Blepharoplasty
Lee, T. C., Fung, S. E., Hu, J. Q., Villatoro, G. A., Park, K. S., Fung, B. M., Groessl, E. J., Korn, B. S., Kikkawa, D. O., & Liu, C. Y. (2024) · Ophthalmic Plastic and Reconstructive Surgery · doi:10.1097/iop.0000000000002649 · Cited by 3
Consequences of Canada’s Drug Agency Reimbursement Recommendations for New Medicines and Pan-Canadian Pharmaceutical Alliance Price Negotiations on Patient Access
Rawson, N. S. B. (2025) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s567932 · Cited by 3
Quality-Adjusted Life Year Gains After Total Hip and Knee Arthroplasty: A Review of Cost-Effectiveness Evidence and Policy Implications
Linton, A. A., Courtney, P. M., Krueger, C. A., Meneghini, R. M., Rana, A. J., & Kugelman, D. N. (2026) · The Journal of Arthroplasty · doi:10.1016/j.arth.2026.02.034 · Cited by 3
Analyzing a Cost-Effectiveness Dataset: A Speech and Language Example for Clinicians
Hoch, J. S., Haynes, S. C., Hearney, S. M., & Dewa, C. S. (2022) · Seminars in Speech and Language · doi:10.1055/s-0042-1750347 · Cited by 3
Obtaining long-term recovery: advances in optimizing treatment outcomes in patients with binge-eating disorder
de Moraes, C. E. F., Donnelly, B., Appolinário, J. C., & Hay, P. (2023) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2023.2273392 · Cited by 3
The price of a QALY—cost-effectiveness of statins in CKD
Jha, V., & Modi, G. K. (2013) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.104 · Cited by 3
Cost-Effectiveness of Osteo-Odonto Keratoprosthesis in Singapore
Dong, D., Tan, A. C. S., Mehta, J. S., Tan, D. T. H., & Finkelstein, E. A. (2013) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2013.08.004 · Cited by 3
Cost‐effectiveness of implantable ventricular assist devices in older children with stable, inotrope‐dependent dilated cardiomyopathy
Avanceña, A. L. V., Hutton, D. W., Lee, J., Schumacher, K. R., Si, M., & Peng, D. M. (2021) · Pediatric Transplantation · doi:10.1111/petr.13975 · Cited by 3

Authors: Grosse, S. D.
Affiliations: Centers for Disease Control and Prevention (US)
Corresponding author: Grosse, Scott D
ORCID: Grosse, Scott D
Venue: Expert Review of Pharmacoeconomics & Outcomes Research
Publisher: Informa UK Limited
Published: 2008-04
Volume: 8
Issue: 2
Pages: 165-178
ISSN: 1473-7167 (ISSN-L)
1744-8379
DOI: 10.1586/14737167.8.2.165
OpenAlex: W2117419474
Cited by: 637
References: 179
Citations by year: 2026: 18 · 2025: 21 · 2024: 20 · 2023: 23 · 2022: 40 · 2021: 40 · 2020: 48 · 2019: 45 · 2018: 40 · 2017: 55 · 2016: 45 · 2015: 58 · 2014: 52 · 2013: 49 · 2012: 32
FWCI: 39.35
Type: journal article
Language: en
Open access: closed
Locations: Expert Review of Pharmacoeconomics & Outcomes Research (publishedVersion)
PubMed (publishedVersion)
Topics: Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Economic and Environmental Valuation
Keywords: cost-effectiveness threshold, quality-adjusted life years, willingness to pay, end-stage renal disease, dialysis, healthcare resource allocation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks